D-1180-2022 Class II Ongoing
FDA drug recall D-1180-2022 was initiated by Golden State Medical Supply Inc. on Mar 16, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 1,424 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 13, 2022
- Initiation Date
- Mar 16, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,424 bottles
Product description
Enalapril Maleate Tablets, USP; 20 mg; 90 tablets, NDC 60429-186-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
Code information
Lots: GS035031, GS035199, 20 mg; 90 tablets, Exp.: 03/2022; Lots: GS036495, GS036904, Exp.: 05/2022; Lots: GS037401, Exp.: 09/2022; Lots: GS037986, GS038359, GS039560, Exp.: 11/2022; Lot: GS041110, Exp.: 12/2022. (NDC: 60429-186-90).
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1180-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026